Our technology and IP enables molecular diagnosis (MDx) of a broad range of diseases including infectious diseases and cancers. The resulting information guides precise and personalized drug treatment. InSilixa achieves this by offering four powerful detection modalities in CMOS. You pick the application, molecular targets and assay type. We create an integrated CMOS biochip for you with dedicated informatics to produce a product that addresses an unmet medical need.
Bring your MDx requirement to us; together we will create an innovative, integrated, transformative, and mass-deployable solution.